NTLA icon

Intellia Therapeutics
NTLA

Overview Fund Trends Analyst Outlook Journalist POV

62 hedge funds and large institutions have $302M invested in Intellia Therapeutics in 2016 Q2 according to their latest regulatory filings, with 62 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
62
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$112M
2
+$56.8M
3
+$22.7M
4
Temasek Holdings
Temasek Holdings
Singapore
+$16.9M
5
FCMI
Foresite Capital Management III
California
+$16.3M

Top Sellers

1
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$553K
27
$534K
28
$497K
29
$486K
30
$462K
31
$433K
32
$430K
33
$425K
34
$374K
35
$374K
36
$320K
37
$313K
38
$244K
39
$235K
40
$223K
41
$190K
42
$168K
43
$154K
44
$117K
45
$102K
46
$100K
47
$97K
48
$85.8K
49
$64K
50
$53K
1
2
3